Health

Palette Life Sciences Launches the Deflux Learning Center, a New Online Resource to Support Healthcare Professionals Who Treat Vesicoureteral Reflux (VUR)

Leave a comment


News Image

As a physician, I’m delighted about this new resource center, which provides valuable information, education and training on VUR and Deflux. – Dr. Christopher Cooper, Board-Certified Pediatric Urologist of the University of Iowa Stead Family Children’s Hospital


SANTA BARBARA, Calif. and STOCKHOLM (PRWEB)

Palette Life Sciences, Inc., a fully integrated life sciences company dedicated to improving patient outcomes, today announces the launch of the Deflux Learning Center, a valuable new online resource to support pediatric urologists who treat vesicoureteral reflux (VUR). The Deflux Learning Center contains comprehensive VUR and Deflux-related information, education, training, tools and resources to help pediatric urologists and pediatricians learn more about VUR and treatment options and provide them with educational materials for referring physicians, administrators and caregivers.

The Deflux Learning Center features:


  • The PedSpace – a new podcast series sponsored by Palette Life Sciences, featuring physicians discussing pediatric urology, VUR and Deflux, as well as broader topics, like telemedicine and more.

  • Educational videos and webinars – including Deflux training videos and webinars on how and when to use Deflux, the injection technique, and content for pediatric urologists to download and share with referring physicians regarding diagnosing and grading VUR.

  • Clinical articles – containing important scientific information pertaining to diagnosing, grading and treating VUR.

  • Brochures and downloadable resources and tools – including physician and caregiver resources, product instructions for use, reimbursement information, and more.

  • Events Calendar – featuring information about upcoming conferences, trainings and other industry events and meetings for physicians.

“As a physician, I’m delighted about this new resource center, which provides valuable information, education and training on VUR and Deflux,” said Dr. Christopher Cooper, Board-Certified Pediatric Urologist of University of Iowa Stead Family Children’s Hospital.

“At Palette Life Sciences, we are delighted to support pediatric urologists and their work to improve patient outcomes. Through the new Deflux Learning Center, we have provided a wide variety of resources that are accessible from anywhere and will greatly help them treat VUR by engaging in new educational content,” said Rich Low, Head of Marketing.

About VUR

Vesicoureteral reflux (VUR), sometimes referred to as urinary or bladder reflux, is a serious pediatric urinary condition in which urine refluxes from the bladder through one or both ureters toward the kidneys. This is due to an abnormality in the region where the ureter meets the bladder. Normally, a valve at the entrance to the bladder prevents backward flow of urine. Infected urine can reflux back into the ureters and, in severe cases, into the kidneys – which may lead to long-term kidney damage. Deflux is a minimally invasive, outpatient procedure that has been proven safe and effective in children with VUR grades II-IV. Deflux is a gel made from two tissue-friendly polysaccharides (types of sugars) – Non-Animal Stabilized Hyaluronic Acid (NASHA®) and dextranomer (Dx) – and is used as a tissue bulking agent that is injected around the ureteral opening to prevent urine from flowing back up from the bladder through the ureters.

About Deflux

Deflux is a minimally invasive, outpatient procedure that has been proven safe and effective in children with VUR. Deflux is a gel made from two tissue-friendly polysaccharides (types of sugars) – hyaluronic acid (HA) and dextranomer (Dx) – and is used as a tissue bulking agent that is injected inside the ureteral opening to prevent urine from flowing back up from the bladder through the ureters. Learn more at Deflux.com.

About Palette Life Sciences AB

Palette Life Sciences is a fully integrated life sciences company. Palette’s products improve patient outcomes in urology and urogynecology disorders, colorectal conditions, radiotherapy, and interventional oncology procedures. The Company’s portfolio of available products includes Deflux®, Solesta® and Barrigel®. Palette Life Sciences moves rapidly to leverage novel applications of existing technologies to create breakthrough medical solutions. This focus enables the company to serve those often overlooked by traditional medical companies and improve patient quality of life. Led by experienced healthcare executives, Palette Life Sciences is headquartered in Stockholm, Sweden, with offices in Santa Barbara, California, and Dallas, Texas. Learn more at http://www.palettelifesciences.com.

© 2020 Palette Life Sciences, Inc. All rights reserved.

Deflux® and NASHA® are registered trademarks. APM203A

Share article on social media or email:

Leave a Reply